Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhengjun Kang

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Journal of Cancer Research and Therapeutics|December 3, 2014
Research progress on bladder cancer molecular geneticsZhengjun Kang, Yuhui Li, Yang Yu, et al.
Scientific Reports|November 10, 2023
Tumor microenvironment heterogeneity in bladder cancer identifies biologically distinct subtypes predicting prognosis and anti-PD-L1 responsesYaFei Li, Yi Liu, Zhengjun Kang, et al.
Translational Cancer Research|February 4, 2022
Nomograms to predict overall and cancer-specific survival in patients with penile cancerWenbo Xu, Feng Qi, Yi Liu, et al.
Frontiers in Genetics|December 5, 2022
Clinical value of M1 macrophage-related genes identification in bladder urothelial carcinoma and <i>in vitro</i> validationYang Yu, Yuexi Huang, Chen Li, et al.
Frontiers in Oncology|March 18, 2022
Identification of a Novel Tumor Microenvironment Prognostic Signature for Bladder Urothelial CarcinomaChaojie Xu, Dongchen Pei, Yi Liu, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|March 18, 2014
Quantitative assessment of the association between miR-196a2 rs11614913 polymorphism and cancer risk: evidence based on 45,816 subjectsZhengjun Kang, Yuhui Li, Xiaokai He, et al.
Scientific Reports|January 15, 2021
Clinical characteristics and overall survival nomogram of second primary malignancies after prostate cancer, a SEER population-based studyYi Liu, Peipei Zhang, Yinghao Zhang, et al.
Frontiers in Oncology|June 1, 2023
Clinical characteristics and prostate-cancer-specific mortality of competitive risk nomogram in the second primary prostate cancerChaojie Xu, Dongchen Pei, Yi Liu, et al.
Frontiers in Oncology|March 22, 2021
CXCL12 and CD3E as Indicators for Tumor Microenvironment Modulation in Bladder Cancer and Their Correlations With Immune Infiltration and Molecular SubtypesYi Liu, YuCai Wu, PeiPei Zhang, et al.
Frontiers in Genetics|September 28, 2020
Identification of the Six-RNA-Binding Protein Signature for Prognosis Prediction in Bladder CancerYucai Wu, Yi Liu, Anbang He, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Journal of Cancer Research and Therapeutics|December 3, 2014
Research progress on bladder cancer molecular geneticsZhengjun Kang, Yuhui Li, Yang Yu, et al.
Scientific Reports|November 10, 2023
Tumor microenvironment heterogeneity in bladder cancer identifies biologically distinct subtypes predicting prognosis and anti-PD-L1 responsesYaFei Li, Yi Liu, Zhengjun Kang, et al.
Translational Cancer Research|February 4, 2022
Nomograms to predict overall and cancer-specific survival in patients with penile cancerWenbo Xu, Feng Qi, Yi Liu, et al.
Frontiers in Genetics|December 5, 2022
Clinical value of M1 macrophage-related genes identification in bladder urothelial carcinoma and <i>in vitro</i> validationYang Yu, Yuexi Huang, Chen Li, et al.
Frontiers in Oncology|March 18, 2022
Identification of a Novel Tumor Microenvironment Prognostic Signature for Bladder Urothelial CarcinomaChaojie Xu, Dongchen Pei, Yi Liu, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|March 18, 2014
Quantitative assessment of the association between miR-196a2 rs11614913 polymorphism and cancer risk: evidence based on 45,816 subjectsZhengjun Kang, Yuhui Li, Xiaokai He, et al.
Scientific Reports|January 15, 2021
Clinical characteristics and overall survival nomogram of second primary malignancies after prostate cancer, a SEER population-based studyYi Liu, Peipei Zhang, Yinghao Zhang, et al.
Frontiers in Oncology|June 1, 2023
Clinical characteristics and prostate-cancer-specific mortality of competitive risk nomogram in the second primary prostate cancerChaojie Xu, Dongchen Pei, Yi Liu, et al.
Frontiers in Oncology|March 22, 2021
CXCL12 and CD3E as Indicators for Tumor Microenvironment Modulation in Bladder Cancer and Their Correlations With Immune Infiltration and Molecular SubtypesYi Liu, YuCai Wu, PeiPei Zhang, et al.
Frontiers in Genetics|September 28, 2020
Identification of the Six-RNA-Binding Protein Signature for Prognosis Prediction in Bladder CancerYucai Wu, Yi Liu, Anbang He, et al.
Pageof 2